Literature DB >> 19430754

[Patient safety based on computer-assisted drug therapy. Electronic check-up of the patient].

T Bertsche1, J Kaltschmidt, W E Haefeli.   

Abstract

Patients in internal medicine frequently experience adverse drug events. Many of those events, however, are avoidable because they are caused by medication errors, which are particularly frequent in drug prescribing. Therefore, practical concepts are needed to make the rapidly growing knowledge on drugs available already during prescription. But also when deviations from standards are intended access to up-to-date information is required. Computer-based systems can offer support for prescribing clinicians to meet these claims and thus improve the quality of pharmacotherapy. To reach this goal, such systems have to be interlinked among each other and with systems of primary, secondary, and tertiary care. They must be based on scientific published evidence and should consider as many factors as possible for individualization of drug therapy. Individualization and focusing on relevant information are prerequisites to prevent inappropriate alerts (over-alerting) and thus to increase acceptance in practical use.

Entities:  

Mesh:

Year:  2009        PMID: 19430754     DOI: 10.1007/s00108-009-2398-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  46 in total

1.  Suspected adverse drug events requiring emergency department visits or hospital admissions.

Authors:  R Raschetti; M Morgutti; F Menniti-Ippolito; A Belisari; A Rossignoli; P Longhini; C La Guidara
Journal:  Eur J Clin Pharmacol       Date:  1999-02       Impact factor: 2.953

2.  Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany.

Authors:  Verena Bergk; Christiane Gasse; Rainer Schnell; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2004-09-04       Impact factor: 2.953

3.  Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department.

Authors:  F Davidsen; T Haghfelt; L F Gram; K Brøsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Prevention of intravenous drug incompatibilities in an intensive care unit.

Authors:  Thilo Bertsche; Yvonne Mayer; Rebekka Stahl; Torsten Hoppe-Tichy; Jens Encke; Walter Emil Haefeli
Journal:  Am J Health Syst Pharm       Date:  2008-10-01       Impact factor: 2.637

5.  Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand.

Authors:  B Janchawee; W Wongpoowarak; T Owatranporn; V Chongsuvivatwong
Journal:  J Clin Pharm Ther       Date:  2005-02       Impact factor: 2.512

Review 6.  Barriers to effective cancer pain management: a review of the literature.

Authors:  K L Pargeon; B J Hailey
Journal:  J Pain Symptom Manage       Date:  1999-11       Impact factor: 3.612

7.  Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature.

Authors:  Verena Bergk; Walter E Haefeli; Christiane Gasse; Hermann Brenner; Meret Martin-Facklam
Journal:  Eur J Clin Pharmacol       Date:  2005-06-28       Impact factor: 2.953

8.  Role of computerized physician order entry systems in facilitating medication errors.

Authors:  Ross Koppel; Joshua P Metlay; Abigail Cohen; Brian Abaluck; A Russell Localio; Stephen E Kimmel; Brian L Strom
Journal:  JAMA       Date:  2005-03-09       Impact factor: 56.272

Review 9.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

10.  Pro-active provision of drug information as a technique to address overdosing in intensive-care patients with renal insufficiency.

Authors:  Thilo Bertsche; Martina Fleischer; Johannes Pfaff; Jens Encke; David Czock; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2009-03-25       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.